Global Immuno-oncology Diagnosis Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 239931
  • calendar_today Published On: Dec, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Immuno-oncology Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Immuno-oncology Diagnosis size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global Immuno-oncology Diagnosis market size is expected to grow at a CAGR of % for the next five years.

Market segmentation

Immuno-oncology Diagnosis market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

PCR

NGS

Immunoassay

Market segment by Application, can be divided into

Research

Diagnostics

Market segment by players, this report covers

10x Genomics

Abbott Laboratories

Abcam

Adaptive Biotechnologies

Aethlon Medical

Agena Bioscience

Angle plc

Apocell

ARUP Laboratories

Beckman Coulter

Becton Dickinson

Bioarray Genetics

BioCartis

Biocept

Biodesix Inc

BioFluidica

BioGenex 40 bioMérieux

Bio-Rad

Bio-Techne

Bristol-Myers Squibb

Cancer Genetics

Caris Molecular Diagnostics

CellMax Life

Charles River Laboratories

Chronix Biomedical

Circulogene

Clearbridge BioMedics

Clinical Genomics

Pfizer

Promega

Protagen Diagnostics

Qiagen

Quanterix

Rarecells SAS

Roche Diagnostics

Siemens

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Immuno-oncology Diagnosis product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Immuno-oncology Diagnosis, with revenue, gross margin and global market share of Immuno-oncology Diagnosis from 2019 to 2021.

Chapter 3, the Immuno-oncology Diagnosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Immuno-oncology Diagnosis market forecast, by regions, technology and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Immuno-oncology Diagnosis research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Immuno-oncology Diagnosis

1.2 Classification of Immuno-oncology Diagnosis by Technology

1.2.1 Overview: Global Immuno-oncology Diagnosis Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Immuno-oncology Diagnosis Revenue Market Share by Type in 2020

1.2.3 PCR

1.2.4 NGS

1.2.5 Immunoassay

1.3 Global Immuno-oncology Diagnosis Market by Application

1.3.1 Overview: Global Immuno-oncology Diagnosis Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Research

1.3.3 Diagnostics

1.4 Global Immuno-oncology Diagnosis Market Size & Forecast

1.5 Global Immuno-oncology Diagnosis Market Size and Forecast by Region

1.5.1 Global Immuno-oncology Diagnosis Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Immuno-oncology Diagnosis Market Size by Region, (2016-2021)

1.5.3 North America Immuno-oncology Diagnosis Market Size and Prospect (2016-2026)

1.5.4 Europe Immuno-oncology Diagnosis Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Immuno-oncology Diagnosis Market Size and Prospect (2016-2026)

1.5.6 South America Immuno-oncology Diagnosis Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Immuno-oncology Diagnosis Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Immuno-oncology Diagnosis Market Drivers

1.6.2 Immuno-oncology Diagnosis Market Restraints

1.6.3 Immuno-oncology Diagnosis Trends Analysis

2 Company Profiles

2.1 10x Genomics

2.1.1 10x Genomics Details

2.1.2 10x Genomics Major Business

2.1.3 10x Genomics Immuno-oncology Diagnosis Product and Solutions

2.1.4 10x Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 10x Genomics Recent Developments and Future Plans

2.2 Abbott Laboratories

2.2.1 Abbott Laboratories Details

2.2.2 Abbott Laboratories Major Business

2.2.3 Abbott Laboratories Immuno-oncology Diagnosis Product and Solutions

2.2.4 Abbott Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Abbott Laboratories Recent Developments and Future Plans

2.3 Abcam

2.3.1 Abcam Details

2.3.2 Abcam Major Business

2.3.3 Abcam Immuno-oncology Diagnosis Product and Solutions

2.3.4 Abcam Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Abcam Recent Developments and Future Plans

2.4 Adaptive Biotechnologies

2.4.1 Adaptive Biotechnologies Details

2.4.2 Adaptive Biotechnologies Major Business

2.4.3 Adaptive Biotechnologies Immuno-oncology Diagnosis Product and Solutions

2.4.4 Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Adaptive Biotechnologies Recent Developments and Future Plans

2.5 Aethlon Medical

2.5.1 Aethlon Medical Details

2.5.2 Aethlon Medical Major Business

2.5.3 Aethlon Medical Immuno-oncology Diagnosis Product and Solutions

2.5.4 Aethlon Medical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Aethlon Medical Recent Developments and Future Plans

2.6 Agena Bioscience

2.6.1 Agena Bioscience Details

2.6.2 Agena Bioscience Major Business

2.6.3 Agena Bioscience Immuno-oncology Diagnosis Product and Solutions

2.6.4 Agena Bioscience Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Agena Bioscience Recent Developments and Future Plans

2.7 Angle plc

2.7.1 Angle plc Details

2.7.2 Angle plc Major Business

2.7.3 Angle plc Immuno-oncology Diagnosis Product and Solutions

2.7.4 Angle plc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Angle plc Recent Developments and Future Plans

2.8 Apocell

2.8.1 Apocell Details

2.8.2 Apocell Major Business

2.8.3 Apocell Immuno-oncology Diagnosis Product and Solutions

2.8.4 Apocell Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Apocell Recent Developments and Future Plans

2.9 ARUP Laboratories

2.9.1 ARUP Laboratories Details

2.9.2 ARUP Laboratories Major Business

2.9.3 ARUP Laboratories Immuno-oncology Diagnosis Product and Solutions

2.9.4 ARUP Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 ARUP Laboratories Recent Developments and Future Plans

2.10 Beckman Coulter

2.10.1 Beckman Coulter Details

2.10.2 Beckman Coulter Major Business

2.10.3 Beckman Coulter Immuno-oncology Diagnosis Product and Solutions

2.10.4 Beckman Coulter Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Beckman Coulter Recent Developments and Future Plans

2.11 Becton Dickinson

2.11.1 Becton Dickinson Details

2.11.2 Becton Dickinson Major Business

2.11.3 Becton Dickinson Immuno-oncology Diagnosis Product and Solutions

2.11.4 Becton Dickinson Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Becton Dickinson Recent Developments and Future Plans

2.12 Bioarray Genetics

2.12.1 Bioarray Genetics Details

2.12.2 Bioarray Genetics Major Business

2.12.3 Bioarray Genetics Immuno-oncology Diagnosis Product and Solutions

2.12.4 Bioarray Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Bioarray Genetics Recent Developments and Future Plans

2.13 BioCartis

2.13.1 BioCartis Details

2.13.2 BioCartis Major Business

2.13.3 BioCartis Immuno-oncology Diagnosis Product and Solutions

2.13.4 BioCartis Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 BioCartis Recent Developments and Future Plans

2.14 Biocept

2.14.1 Biocept Details

2.14.2 Biocept Major Business

2.14.3 Biocept Immuno-oncology Diagnosis Product and Solutions

2.14.4 Biocept Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Biocept Recent Developments and Future Plans

2.15 Biodesix Inc

2.15.1 Biodesix Inc Details

2.15.2 Biodesix Inc Major Business

2.15.3 Biodesix Inc Immuno-oncology Diagnosis Product and Solutions

2.15.4 Biodesix Inc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Biodesix Inc Recent Developments and Future Plans

2.16 BioFluidica

2.16.1 BioFluidica Details

2.16.2 BioFluidica Major Business

2.16.3 BioFluidica Immuno-oncology Diagnosis Product and Solutions

2.16.4 BioFluidica Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 BioFluidica Recent Developments and Future Plans

2.17 BioGenex 40 bioMérieux

2.17.1 BioGenex 40 bioMérieux Details

2.17.2 BioGenex 40 bioMérieux Major Business

2.17.3 BioGenex 40 bioMérieux Immuno-oncology Diagnosis Product and Solutions

2.17.4 BioGenex 40 bioMérieux Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 BioGenex 40 bioMérieux Recent Developments and Future Plans

2.18 Bio-Rad

2.18.1 Bio-Rad Details

2.18.2 Bio-Rad Major Business

2.18.3 Bio-Rad Immuno-oncology Diagnosis Product and Solutions

2.18.4 Bio-Rad Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Bio-Rad Recent Developments and Future Plans

2.19 Bio-Techne

2.19.1 Bio-Techne Details

2.19.2 Bio-Techne Major Business

2.19.3 Bio-Techne Immuno-oncology Diagnosis Product and Solutions

2.19.4 Bio-Techne Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Bio-Techne Recent Developments and Future Plans

2.20 Bristol-Myers Squibb

2.20.1 Bristol-Myers Squibb Details

2.20.2 Bristol-Myers Squibb Major Business

2.20.3 Bristol-Myers Squibb Immuno-oncology Diagnosis Product and Solutions

2.20.4 Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.21 Cancer Genetics

2.21.1 Cancer Genetics Details

2.21.2 Cancer Genetics Major Business

2.21.3 Cancer Genetics Immuno-oncology Diagnosis Product and Solutions

2.21.4 Cancer Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 Cancer Genetics Recent Developments and Future Plans

2.22 Caris Molecular Diagnostics

2.22.1 Caris Molecular Diagnostics Details

2.22.2 Caris Molecular Diagnostics Major Business

2.22.3 Caris Molecular Diagnostics Immuno-oncology Diagnosis Product and Solutions

2.22.4 Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.22.5 Caris Molecular Diagnostics Recent Developments and Future Plans

2.23 CellMax Life

2.23.1 CellMax Life Details

2.23.2 CellMax Life Major Business

2.23.3 CellMax Life Immuno-oncology Diagnosis Product and Solutions

2.23.4 CellMax Life Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.23.5 CellMax Life Recent Developments and Future Plans

2.24 Charles River Laboratories

2.24.1 Charles River Laboratories Details

2.24.2 Charles River Laboratories Major Business

2.24.3 Charles River Laboratories Immuno-oncology Diagnosis Product and Solutions

2.24.4 Charles River Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.24.5 Charles River Laboratories Recent Developments and Future Plans

2.25 Chronix Biomedical

2.25.1 Chronix Biomedical Details

2.25.2 Chronix Biomedical Major Business

2.25.3 Chronix Biomedical Immuno-oncology Diagnosis Product and Solutions

2.25.4 Chronix Biomedical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.25.5 Chronix Biomedical Recent Developments and Future Plans

2.26 Circulogene

2.26.1 Circulogene Details

2.26.2 Circulogene Major Business

2.26.3 Circulogene Immuno-oncology Diagnosis Product and Solutions

2.26.4 Circulogene Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.26.5 Circulogene Recent Developments and Future Plans

2.27 Clearbridge BioMedics

2.27.1 Clearbridge BioMedics Details

2.27.2 Clearbridge BioMedics Major Business

2.27.3 Clearbridge BioMedics Immuno-oncology Diagnosis Product and Solutions

2.27.4 Clearbridge BioMedics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.27.5 Clearbridge BioMedics Recent Developments and Future Plans

2.28 Clinical Genomics

2.28.1 Clinical Genomics Details

2.28.2 Clinical Genomics Major Business

2.28.3 Clinical Genomics Immuno-oncology Diagnosis Product and Solutions

2.28.4 Clinical Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.28.5 Clinical Genomics Recent Developments and Future Plans

2.29 Pfizer

2.29.1 Pfizer Details

2.29.2 Pfizer Major Business

2.29.3 Pfizer Immuno-oncology Diagnosis Product and Solutions

2.29.4 Pfizer Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.29.5 Pfizer Recent Developments and Future Plans

2.30 Promega

2.30.1 Promega Details

2.30.2 Promega Major Business

2.30.3 Promega Immuno-oncology Diagnosis Product and Solutions

2.30.4 Promega Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.30.5 Promega Recent Developments and Future Plans

2.31 Protagen Diagnostics

2.31.1 Protagen Diagnostics Details

2.31.2 Protagen Diagnostics Major Business

2.31.3 Protagen Diagnostics Immuno-oncology Diagnosis Product and Solutions

2.31.4 Protagen Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.31.5 Protagen Diagnostics Recent Developments and Future Plans

2.32 Qiagen

2.32.1 Qiagen Details

2.32.2 Qiagen Major Business

2.32.3 Qiagen Immuno-oncology Diagnosis Product and Solutions

2.32.4 Qiagen Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.32.5 Qiagen Recent Developments and Future Plans

2.33 Quanterix

2.33.1 Quanterix Details

2.33.2 Quanterix Major Business

2.33.3 Quanterix Immuno-oncology Diagnosis Product and Solutions

2.33.4 Quanterix Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.33.5 Quanterix Recent Developments and Future Plans

2.34 Rarecells SAS

2.34.1 Rarecells SAS Details

2.34.2 Rarecells SAS Major Business

2.34.3 Rarecells SAS Immuno-oncology Diagnosis Product and Solutions

2.34.4 Rarecells SAS Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.34.5 Rarecells SAS Recent Developments and Future Plans

2.35 Roche Diagnostics

2.35.1 Roche Diagnostics Details

2.35.2 Roche Diagnostics Major Business

2.35.3 Roche Diagnostics Immuno-oncology Diagnosis Product and Solutions

2.35.4 Roche Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.35.5 Roche Diagnostics Recent Developments and Future Plans

2.36 Siemens

2.36.1 Siemens Details

2.36.2 Siemens Major Business

2.36.3 Siemens Immuno-oncology Diagnosis Product and Solutions

2.36.4 Siemens Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.36.5 Siemens Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Immuno-oncology Diagnosis Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Immuno-oncology Diagnosis Players Market Share

3.2.2 Top 10 Immuno-oncology Diagnosis Players Market Share

3.2.3 Market Competition Trend

3.3 Immuno-oncology Diagnosis Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Immuno-oncology Diagnosis Revenue and Market Share by Type (2016-2021)

4.2 Global Immuno-oncology Diagnosis Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Immuno-oncology Diagnosis Revenue Market Share by Application (2016-2021)

5.2 Immuno-oncology Diagnosis Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Immuno-oncology Diagnosis Revenue by Type (2016-2026)

6.2 North America Immuno-oncology Diagnosis Revenue by Application (2016-2026)

6.3 North America Immuno-oncology Diagnosis Market Size by Country

6.3.1 North America Immuno-oncology Diagnosis Revenue by Country (2016-2026)

6.3.2 United States Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

6.3.3 Canada Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

6.3.4 Mexico Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Immuno-oncology Diagnosis Revenue by Type (2016-2026)

7.2 Europe Immuno-oncology Diagnosis Revenue by Application (2016-2026)

7.3 Europe Immuno-oncology Diagnosis Market Size by Country

7.3.1 Europe Immuno-oncology Diagnosis Revenue by Country (2016-2026)

7.3.2 Germany Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

7.3.3 France Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

7.3.5 Russia Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

7.3.6 Italy Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Immuno-oncology Diagnosis Revenue by Type (2016-2026)

8.2 Asia-Pacific Immuno-oncology Diagnosis Revenue by Application (2016-2026)

8.3 Asia-Pacific Immuno-oncology Diagnosis Market Size by Region

8.3.1 Asia-Pacific Immuno-oncology Diagnosis Revenue by Region (2016-2026)

8.3.2 China Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

8.3.3 Japan Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

8.3.4 South Korea Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

8.3.5 India Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

8.3.7 Australia Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Immuno-oncology Diagnosis Revenue by Type (2016-2026)

9.2 South America Immuno-oncology Diagnosis Revenue by Application (2016-2026)

9.3 South America Immuno-oncology Diagnosis Market Size by Country

9.3.1 South America Immuno-oncology Diagnosis Revenue by Country (2016-2026)

9.3.2 Brazil Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

9.3.3 Argentina Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Immuno-oncology Diagnosis Revenue by Type (2016-2026)

10.2 Middle East & Africa Immuno-oncology Diagnosis Revenue by Application (2016-2026)

10.3 Middle East & Africa Immuno-oncology Diagnosis Market Size by Country

10.3.1 Middle East & Africa Immuno-oncology Diagnosis Revenue by Country (2016-2026)

10.3.2 Turkey Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

10.3.4 UAE Immuno-oncology Diagnosis Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Immuno-oncology Diagnosis Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Immuno-oncology Diagnosis Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Immuno-oncology Diagnosis Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Immuno-oncology Diagnosis Revenue (USD Million) by Region (2016-2021)

Table 5. Global Immuno-oncology Diagnosis Revenue Market Share by Region (2021-2026)

Table 6. 10x Genomics Corporate Information, Head Office, and Major Competitors

Table 7. 10x Genomics Major Business

Table 8. 10x Genomics Immuno-oncology Diagnosis Product and Solutions

Table 9. 10x Genomics Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 11. Abbott Laboratories Major Business

Table 12. Abbott Laboratories Immuno-oncology Diagnosis Product and Solutions

Table 13. Abbott Laboratories Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Abcam Corporate Information, Head Office, and Major Competitors

Table 15. Abcam Major Business

Table 16. Abcam Immuno-oncology Diagnosis Product and Solutions

Table 17. Abcam Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Adaptive Biotechnologies Corporate Information, Head Office, and Major Competitors

Table 19. Adaptive Biotechnologies Major Business

Table 20. Adaptive Biotechnologies Immuno-oncology Diagnosis Product and Solutions

Table 21. Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Aethlon Medical Corporate Information, Head Office, and Major Competitors

Table 23. Aethlon Medical Major Business

Table 24. Aethlon Medical Immuno-oncology Diagnosis Product and Solutions

Table 25. Aethlon Medical Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Agena Bioscience Corporate Information, Head Office, and Major Competitors

Table 27. Agena Bioscience Major Business

Table 28. Agena Bioscience Immuno-oncology Diagnosis Product and Solutions

Table 29. Agena Bioscience Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Angle plc Corporate Information, Head Office, and Major Competitors

Table 31. Angle plc Major Business

Table 32. Angle plc Immuno-oncology Diagnosis Product and Solutions

Table 33. Angle plc Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Apocell Corporate Information, Head Office, and Major Competitors

Table 35. Apocell Major Business

Table 36. Apocell Immuno-oncology Diagnosis Product and Solutions

Table 37. Apocell Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. ARUP Laboratories Corporate Information, Head Office, and Major Competitors

Table 39. ARUP Laboratories Major Business

Table 40. ARUP Laboratories Immuno-oncology Diagnosis Product and Solutions

Table 41. ARUP Laboratories Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Beckman Coulter Corporate Information, Head Office, and Major Competitors

Table 43. Beckman Coulter Major Business

Table 44. Beckman Coulter Immuno-oncology Diagnosis Product and Solutions

Table 45. Beckman Coulter Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Becton Dickinson Corporate Information, Head Office, and Major Competitors

Table 47. Becton Dickinson Major Business

Table 48. Becton Dickinson Immuno-oncology Diagnosis Product and Solutions

Table 49. Becton Dickinson Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Bioarray Genetics Corporate Information, Head Office, and Major Competitors

Table 51. Bioarray Genetics Major Business

Table 52. Bioarray Genetics Immuno-oncology Diagnosis Product and Solutions

Table 53. Bioarray Genetics Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. BioCartis Corporate Information, Head Office, and Major Competitors

Table 55. BioCartis Major Business

Table 56. BioCartis Immuno-oncology Diagnosis Product and Solutions

Table 57. BioCartis Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Biocept Corporate Information, Head Office, and Major Competitors

Table 59. Biocept Major Business

Table 60. Biocept Immuno-oncology Diagnosis Product and Solutions

Table 61. Biocept Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Biodesix Inc Corporate Information, Head Office, and Major Competitors

Table 63. Biodesix Inc Major Business

Table 64. Biodesix Inc Immuno-oncology Diagnosis Product and Solutions

Table 65. Biodesix Inc Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. BioFluidica Corporate Information, Head Office, and Major Competitors

Table 67. BioFluidica Major Business

Table 68. BioFluidica Immuno-oncology Diagnosis Product and Solutions

Table 69. BioFluidica Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. BioGenex 40 bioMérieux Corporate Information, Head Office, and Major Competitors

Table 71. BioGenex 40 bioMérieux Major Business

Table 72. BioGenex 40 bioMérieux Immuno-oncology Diagnosis Product and Solutions

Table 73. BioGenex 40 bioMérieux Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Bio-Rad Corporate Information, Head Office, and Major Competitors

Table 75. Bio-Rad Major Business

Table 76. Bio-Rad Immuno-oncology Diagnosis Product and Solutions

Table 77. Bio-Rad Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Bio-Techne Corporate Information, Head Office, and Major Competitors

Table 79. Bio-Techne Major Business

Table 80. Bio-Techne Immuno-oncology Diagnosis Product and Solutions

Table 81. Bio-Techne Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 83. Bristol-Myers Squibb Major Business

Table 84. Bristol-Myers Squibb Immuno-oncology Diagnosis Product and Solutions

Table 85. Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Cancer Genetics Corporate Information, Head Office, and Major Competitors

Table 87. Cancer Genetics Major Business

Table 88. Cancer Genetics Immuno-oncology Diagnosis Product and Solutions

Table 89. Cancer Genetics Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. Caris Molecular Diagnostics Corporate Information, Head Office, and Major Competitors

Table 91. Caris Molecular Diagnostics Major Business

Table 92. Caris Molecular Diagnostics Immuno-oncology Diagnosis Product and Solutions

Table 93. Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 94. CellMax Life Corporate Information, Head Office, and Major Competitors

Table 95. CellMax Life Major Business

Table 96. CellMax Life Immuno-oncology Diagnosis Product and Solutions

Table 97. CellMax Life Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 98. Charles River Laboratories Corporate Information, Head Office, and Major Competitors

Table 99. Charles River Laboratories Major Business

Table 100. Charles River Laboratories Immuno-oncology Diagnosis Product and Solutions

Table 101. Charles River Laboratories Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 102. Chronix Biomedical Corporate Information, Head Office, and Major Competitors

Table 103. Chronix Biomedical Major Business

Table 104. Chronix Biomedical Immuno-oncology Diagnosis Product and Solutions

Table 105. Chronix Biomedical Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 106. Circulogene Corporate Information, Head Office, and Major Competitors

Table 107. Circulogene Major Business

Table 108. Circulogene Immuno-oncology Diagnosis Product and Solutions

Table 109. Circulogene Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 110. Clearbridge BioMedics Corporate Information, Head Office, and Major Competitors

Table 111. Clearbridge BioMedics Major Business

Table 112. Clearbridge BioMedics Immuno-oncology Diagnosis Product and Solutions

Table 113. Clearbridge BioMedics Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 114. Clinical Genomics Corporate Information, Head Office, and Major Competitors

Table 115. Clinical Genomics Major Business

Table 116. Clinical Genomics Immuno-oncology Diagnosis Product and Solutions

Table 117. Clinical Genomics Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 118. Pfizer Corporate Information, Head Office, and Major Competitors

Table 119. Pfizer Major Business

Table 120. Pfizer Immuno-oncology Diagnosis Product and Solutions

Table 121. Pfizer Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 122. Promega Corporate Information, Head Office, and Major Competitors

Table 123. Promega Major Business

Table 124. Promega Immuno-oncology Diagnosis Product and Solutions

Table 125. Promega Immuno-oncology Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 126. Global Immuno-oncology Diagnosis Revenue (USD Million) by Players (2019-2021)

Table 127. Global Immuno-oncology Diagnosis Revenue Share by Players (2019-2021)

Table 128. Breakdown of Immuno-oncology Diagnosis by Company Type (Tier 1, Tier 2 and Tier 3)

Table 129. Immuno-oncology Diagnosis Players Head Office, Products and Services Provided

Table 130. Immuno-oncology Diagnosis Mergers & Acquisitions in the Past Five Years

Table 131. Immuno-oncology Diagnosis New Entrants and Expansion Plans

Table 132. Global Immuno-oncology Diagnosis Revenue (USD Million) by Type (2016-2021)

Table 133. Global Immuno-oncology Diagnosis Revenue Share by Type (2016-2021)

Table 134. Global Immuno-oncology Diagnosis Revenue Forecast by Type (2021-2026)

Table 135. Global Immuno-oncology Diagnosis Revenue by Application (2016-2021)

Table 136. Global Immuno-oncology Diagnosis Revenue Forecast by Application (2021-2026)

Table 137. North America Immuno-oncology Diagnosis Revenue by Type (2016-2021) & (USD Million)

Table 138. North America Immuno-oncology Diagnosis Revenue by Type (2021-2026) & (USD Million)

Table 139. North America Immuno-oncology Diagnosis Revenue by Application (2016-2021) & (USD Million)

Table 140. North America Immuno-oncology Diagnosis Revenue by Application (2021-2026) & (USD Million)

Table 141. North America Immuno-oncology Diagnosis Revenue by Country (2016-2021) & (USD Million)

Table 142. North America Immuno-oncology Diagnosis Revenue by Country (2021-2026) & (USD Million)

Table 143. Europe Immuno-oncology Diagnosis Revenue by Type (2016-2021) & (USD Million)

Table 144. Europe Immuno-oncology Diagnosis Revenue by Type (2021-2026) & (USD Million)

Table 145. Europe Immuno-oncology Diagnosis Revenue by Application (2016-2021) & (USD Million)

Table 146. Europe Immuno-oncology Diagnosis Revenue by Application (2021-2026) & (USD Million)

Table 147. Europe Immuno-oncology Diagnosis Revenue by Country (2016-2021) & (USD Million)

Table 148. Europe Immuno-oncology Diagnosis Revenue by Country (2021-2026) & (USD Million)

Table 149. Asia-Pacific Immuno-oncology Diagnosis Revenue by Type (2016-2021) & (USD Million)

Table 150. Asia-Pacific Immuno-oncology Diagnosis Revenue by Type (2021-2026) & (USD Million)

Table 151. Asia-Pacific Immuno-oncology Diagnosis Revenue by Application (2016-2021) & (USD Million)

Table 152. Asia-Pacific Immuno-oncology Diagnosis Revenue by Application (2021-2026) & (USD Million)

Table 153. Asia-Pacific Immuno-oncology Diagnosis Revenue by Region (2016-2021) & (USD Million)

Table 154. Asia-Pacific Immuno-oncology Diagnosis Revenue by Region (2021-2026) & (USD Million)

Table 155. South America Immuno-oncology Diagnosis Revenue by Type (2016-2021) & (USD Million)

Table 156. South America Immuno-oncology Diagnosis Revenue by Type (2021-2026) & (USD Million)

Table 157. South America Immuno-oncology Diagnosis Revenue by Application (2016-2021) & (USD Million)

Table 158. South America Immuno-oncology Diagnosis Revenue by Application (2021-2026) & (USD Million)

Table 159. South America Immuno-oncology Diagnosis Revenue by Country (2016-2021) & (USD Million)

Table 160. South America Immuno-oncology Diagnosis Revenue by Country (2021-2026) & (USD Million)

Table 161. Middle East & Africa Immuno-oncology Diagnosis Revenue by Type (2016-2021) & (USD Million)

Table 162. Middle East & Africa Immuno-oncology Diagnosis Revenue by Type (2021-2026) & (USD Million)

Table 163. Middle East & Africa Immuno-oncology Diagnosis Revenue by Application (2016-2021) & (USD Million)

Table 164. Middle East & Africa Immuno-oncology Diagnosis Revenue by Application (2021-2026) & (USD Million)

Table 165. Middle East & Africa Immuno-oncology Diagnosis Revenue by Country (2016-2021) & (USD Million)

Table 166. Middle East & Africa Immuno-oncology Diagnosis Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Immuno-oncology Diagnosis Picture

Figure 2. Global Immuno-oncology Diagnosis Revenue Market Share by Technology in 2020

Figure 3. PCR

Figure 4. NGS

Figure 5. Immunoassay

Figure 6. Immuno-oncology Diagnosis Revenue Market Share by Application in 2020

Figure 7. Research Picture

Figure 8. Diagnostics Picture

Figure 9. Global Immuno-oncology Diagnosis Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Immuno-oncology Diagnosis Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Immuno-oncology Diagnosis Revenue Market Share by Region (2016-2026)

Figure 12. Global Immuno-oncology Diagnosis Revenue Market Share by Region in 2020

Figure 13. North America Immuno-oncology Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Immuno-oncology Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Immuno-oncology Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Immuno-oncology Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Immuno-oncology Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Immuno-oncology Diagnosis Market Drivers

Figure 19. Immuno-oncology Diagnosis Market Restraints

Figure 20. Immuno-oncology Diagnosis Market Trends

Figure 21. 10x Genomics Recent Developments and Future Plans

Figure 22. Abbott Laboratories Recent Developments and Future Plans

Figure 23. Abcam Recent Developments and Future Plans

Figure 24. Adaptive Biotechnologies Recent Developments and Future Plans

Figure 25. Aethlon Medical Recent Developments and Future Plans

Figure 26. Agena Bioscience Recent Developments and Future Plans

Figure 27. Angle plc Recent Developments and Future Plans

Figure 28. Apocell Recent Developments and Future Plans

Figure 29. ARUP Laboratories Recent Developments and Future Plans

Figure 30. Beckman Coulter Recent Developments and Future Plans

Figure 31. Becton Dickinson Recent Developments and Future Plans

Figure 32. Bioarray Genetics Recent Developments and Future Plans

Figure 33. BioCartis Recent Developments and Future Plans

Figure 34. Biocept Recent Developments and Future Plans

Figure 35. Biodesix Inc Recent Developments and Future Plans

Figure 36. BioFluidica Recent Developments and Future Plans

Figure 37. BioGenex 40 bioMérieux Recent Developments and Future Plans

Figure 38. Bio-Rad Recent Developments and Future Plans

Figure 39. Bio-Techne Recent Developments and Future Plans

Figure 40. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 41. Cancer Genetics Recent Developments and Future Plans

Figure 42. Caris Molecular Diagnostics Recent Developments and Future Plans

Figure 43. CellMax Life Recent Developments and Future Plans

Figure 44. Charles River Laboratories Recent Developments and Future Plans

Figure 45. Chronix Biomedical Recent Developments and Future Plans

Figure 46. Circulogene Recent Developments and Future Plans

Figure 47. Clearbridge BioMedics Recent Developments and Future Plans

Figure 48. Clinical Genomics Recent Developments and Future Plans

Figure 49. Pfizer Recent Developments and Future Plans

Figure 50. Promega Recent Developments and Future Plans

Figure 51. Global Immuno-oncology Diagnosis Revenue Share by Players in 2020

Figure 52. Immuno-oncology Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 53. Global Top 3 Players Immuno-oncology Diagnosis Revenue Market Share in 2020

Figure 54. Global Top 10 Players Immuno-oncology Diagnosis Revenue Market Share in 2020

Figure 55. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 56. Global Immuno-oncology Diagnosis Revenue Share by Type in 2020

Figure 57. Global Immuno-oncology Diagnosis Market Share Forecast by Type (2021-2026)

Figure 58. Global Immuno-oncology Diagnosis Revenue Share by Application in 2020

Figure 59. Global Immuno-oncology Diagnosis Market Share Forecast by Application (2021-2026)

Figure 60. North America Immuno-oncology Diagnosis Sales Market Share by Type (2016-2026)

Figure 61. North America Immuno-oncology Diagnosis Sales Market Share by Application (2016-2026)

Figure 62. North America Immuno-oncology Diagnosis Revenue Market Share by Country (2016-2026)

Figure 63. United States Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Canada Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Mexico Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Europe Immuno-oncology Diagnosis Sales Market Share by Type (2016-2026)

Figure 67. Europe Immuno-oncology Diagnosis Sales Market Share by Application (2016-2026)

Figure 68. Europe Immuno-oncology Diagnosis Revenue Market Share by Country (2016-2026)

Figure 69. Germany Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. France Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. United Kingdom Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Russia Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Italy Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Asia-Pacific Immuno-oncology Diagnosis Sales Market Share by Type (2016-2026)

Figure 75. Asia-Pacific Immuno-oncology Diagnosis Sales Market Share by Application (2016-2026)

Figure 76. Asia-Pacific Immuno-oncology Diagnosis Revenue Market Share by Region (2016-2026)

Figure 77. China Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Japan Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. South Korea Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. India Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Southeast Asia Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Australia Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. South America Immuno-oncology Diagnosis Sales Market Share by Type (2016-2026)

Figure 84. South America Immuno-oncology Diagnosis Sales Market Share by Application (2016-2026)

Figure 85. South America Immuno-oncology Diagnosis Revenue Market Share by Country (2016-2026)

Figure 86. Brazil Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 87. Argentina Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 88. Middle East and Africa Immuno-oncology Diagnosis Sales Market Share by Type (2016-2026)

Figure 89. Middle East and Africa Immuno-oncology Diagnosis Sales Market Share by Application (2016-2026)

Figure 90. Middle East and Africa Immuno-oncology Diagnosis Revenue Market Share by Country (2016-2026)

Figure 91. Turkey Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 92. Saudi Arabia Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 93. UAE Immuno-oncology Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 94. Methodology

Figure 95. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz